Literature DB >> 3503559

Report of the Ad Hoc Committee on Nomenclature and Standards for Bone Proteins and Growth Factors.

P V Hauschka, K G Mann, P Price, J D Termine.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3503559     DOI： 10.1002/jbmr.5650010513

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN： 0884-0431            Impact factor:   6.741


× No keyword cloud information.
  5 in total

Review 1.  The role of YKL-40 in the pathogenesis of autoimmune diseases: a comprehensive review.

Authors:  Kalthoum Tizaoui; Jae Won Yang; Keum Hwa Lee; Ji Hong Kim; Minseok Kim; Sojung Yoon; Yeonwoo Jung; Joon Beom Park; Kitae An; Hyeok Choi; Donggyu Song; HyunTaek Jung; Seongmin Ahn; Taeho Yuh; Hee Min Choi; Jae Ha Ahn; Younjuong Kim; Sanghyun Jee; Hyeongsun Lee; Soohwa Jin; Jun-Gu Kang; Bohyun Koo; Joo Yeop Lee; Kyoung Min Min; Wonseok Yoo; Hyeong Jun Rhyu; Yeonjung Yoon; Min Ho Lee; Sung Eun Kim; Jimin Hwang; Ai Koyanagi; Louis Jacob; Seoyeon Park; Jae Il Shin; Lee Smith
Journal:  Int J Biol Sci       Date:  2022-05-21       Impact factor: 10.750

2.  Elevation in circulating YKL-40 concentration in patients with cerebrovascular disease.

Authors:  Xue Xu; Hongling Ma; Jia Xu; Haiwei Huang; Xiaohong Wu; Yan Xiong; Hong Zhan; Fan Huang
Journal:  Bosn J Basic Med Sci       Date:  2014-08-14       Impact factor: 3.363

3.  Biomarkers of delayed graft function as a form of acute kidney injury in kidney transplantation.

Authors:  Jolanta Malyszko; Ewelina Lukaszyk; Irena Glowinska; Magdalena Durlik
Journal:  Sci Rep       Date:  2015-07-15       Impact factor: 4.379

4.  Estimation of YKL-40 Acute-Phase Protein in Serum of Patients with Periodontal Disease and Healthy Individuals: A Clinical-Biochemical Study.

Authors:  Vinay Chavan; Srinu Sabavath; C Hemachandra Babu; Laxman Boyapati
Journal:  Contemp Clin Dent       Date:  2019 Apr-Jun

Review 5.  YKL-40--an emerging biomarker in cardiovascular disease and diabetes.

Authors:  Camilla N Rathcke; Henrik Vestergaard
Journal:  Cardiovasc Diabetol       Date:  2009-11-23       Impact factor: 9.951
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.